273 related articles for article (PubMed ID: 25837166)
1. IL28B is associated with outcomes of chronic HBV infection.
Shi X; Chi X; Pan Y; Gao Y; Li W; Yang C; Zhong J; Xu D; Zhang M; Minuk G; Jiang J; Niu J
Yonsei Med J; 2015 May; 56(3):625-33. PubMed ID: 25837166
[TBL] [Abstract][Full Text] [Related]
2. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population.
Li W; Jiang Y; Jin Q; Shi X; Jin J; Gao Y; Pan Y; Zhang H; Jiang J; Niu J
Liver Int; 2011 Sep; 31(8):1118-26. PubMed ID: 21745278
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma.
Ren S; Lu J; Du X; Huang Y; Ma L; Huo H; Chen X; Wei L
Cancer Immunol Immunother; 2012 Sep; 61(9):1433-9. PubMed ID: 22310928
[TBL] [Abstract][Full Text] [Related]
4. IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.
Holmes JA; Nguyen T; Ratnam D; Heerasing NM; Tehan JV; Bonanzinga S; Dev A; Bell S; Pianko S; Chen R; Visvanathan K; Hammond R; Iser D; Rusli F; Sievert W; Desmond PV; Bowden DS; Thompson AJ
J Gastroenterol Hepatol; 2013 May; 28(5):861-6. PubMed ID: 23301835
[TBL] [Abstract][Full Text] [Related]
5. Frequency of interleukin 28B rs12979860 C>T variants in Filipino patients chronically infected with hepatitis B virus.
Baclig MO; Reyes KG; Mapua CA; Gopez-Cervantes J; Natividad FF;
Mol Biol Rep; 2015 Mar; 42(3):673-9. PubMed ID: 25391769
[TBL] [Abstract][Full Text] [Related]
6. Impact of IL28B and
Domagalski K; Pawłowska M; Zaleśna A; Pilarczyk M; Rajewski P; Halota W; Tretyn A
World J Gastroenterol; 2016 Nov; 22(41):9186-9195. PubMed ID: 27895405
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.
Kimkong I; Chankaew J; Kunanopparat A; Hirankarn N; Tangkijvanich P
Tissue Antigens; 2015 Mar; 85(3):177-81. PubMed ID: 25664396
[TBL] [Abstract][Full Text] [Related]
8. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B.
Sonneveld MJ; Wong VW; Woltman AM; Wong GL; Cakaloglu Y; Zeuzem S; Buster EH; Uitterlinden AG; Hansen BE; Chan HL; Janssen HL
Gastroenterology; 2012 Mar; 142(3):513-520.e1. PubMed ID: 22108195
[TBL] [Abstract][Full Text] [Related]
10. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
11. No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
Wei L; Wedemeyer H; Liaw YF; Chan HL; Piratvisuth T; Marcellin P; Jia J; Tan D; Chow WC; Brunetto MR; Diago M; Gurel S; Morozov V; He H; Zhu Y; Wat C; Surujbally B; Thompson AJ
PLoS One; 2018; 13(7):e0199198. PubMed ID: 30016335
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population.
Yao JY; Chao K; Li MR; Wu YQ; Zhong BH
World J Gastroenterol; 2015 Apr; 21(14):4232-9. PubMed ID: 25892873
[TBL] [Abstract][Full Text] [Related]
13. Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B.
Wu H; Zhao G; Qian F; Liu K; Xie J; Zhou H; Xu J; Xu Y; Han Y; Xie Q; Wang H
Liver Int; 2015 Feb; 35(2):473-81. PubMed ID: 24517415
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence.
Lee DH; Cho Y; Seo JY; Kwon JH; Cho EJ; Jang ES; Kwak MS; Cheong JY; Cho SW; Lee JH; Yu SJ; Yoon JH; Lee HS; Kim CY; Shin HD; Kim YJ
Intervirology; 2013; 56(2):84-90. PubMed ID: 23343781
[TBL] [Abstract][Full Text] [Related]
15. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
Song XM; Li QL; Guo F; Peng H; Guo JJ
Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
[TBL] [Abstract][Full Text] [Related]
17. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.
Pan Q; Zhang RN; Wang YQ; Zheng RD; Mi YQ; Liu WB; Shen F; Chen GY; Lu JF; Zhu CY; Zhang SY; Chen YM; Sun WL; Fan JG
World J Gastroenterol; 2015 Jul; 21(28):8605-14. PubMed ID: 26229402
[TBL] [Abstract][Full Text] [Related]
18. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Uridine⁻Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the Development of Hepatocellular Carcinoma in Cirrhotic Chronic Hepatitis C Patients-A Pilot Study.
Buivydiene A; Liakina V; Kashuba E; Norkuniene J; Jokubauskiene S; Gineikiene E; Valantinas J
Medicina (Kaunas); 2018 Sep; 54(5):. PubMed ID: 30344298
[No Abstract] [Full Text] [Related]
20. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
